Roumell - Harbet

Discussion in 'Enzo Laboratories' started by anonymous, Apr 11, 2019 at 9:10 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Stock is creeping up.

    > 10% ownership -

    Both would like seats on the board, both would like to see the failing asset sold off.
     

  2. anonymous

    anonymous Guest

    What is the failing asset? Sorry. I"m new to this.
     
  3. anonymous

    anonymous Guest

    The LAB, it's the loss leader
     
  4. anonymous

    anonymous Guest

    Harbert reports 6.92% stake in Enzo Biochem, to hold further board talks Harbert Discovery Fund disclosed a 6.92% stake in Enzo Biochem, saying the position was "based on their belief that the securities were undervalued and represented an attractive investment opportunity." The fund also discloses that it "had and anticipate having further conversations with members of the Issuer's management and board of directors regarding possible ways to enhance shareholder value."
     
  5. anonymous

    anonymous Guest

    Nice cut and paste Nimron. Rumor has it you’ve won the coveted accurate jackass of the month award for March.
     
  6. anonymous

    anonymous Guest

    Real deal
     
  7. anonymous

    anonymous Guest

    Enzo Biochem this week issued a letter to its shareholders encouraging them to reject a move by Harbert Discovery Fund to replace two of Enzo's directors Bruce Hanna and Barry Weiner from its current board. Both are up for reelection at Enzo's annual shareholders' meeting on Jan. 31, 2020. "We can only interpret their behavior as an indication that their true intent in obtaining board seats is to abandon Enzo's long-term strategy and attempt a fire sale of the company at depressed valuations," the company said in its letter encouraging shareholders to reelect Hanna and Weiner.
     
  8. anonymous

    anonymous Guest

    Everything Harbert has stated about current management and the board is true. Look at their yearly statements and how much money there management makes. Insane! Also why is their CFO on the Board? the CFO should report to the board, not get a vote on it! This company is headed for bankruptcy is Harbert loses. 2019 would be a disaster if Enzo did not get a $28m settlement from a lawsuit. they would have lost over $25m! Crazy!
     
  9. anonymous

    anonymous Guest

    How do you have three lab customers buying an LDT?

    Isn’t that against the FDA to manufacture and distribute non IVD products?

    I’m sure after today’s earnings call a letter from the FDA is forthcoming.
     
  10. anonymous

    anonymous Guest

    LDT can only be run by the lab that developed the test unless it is FDA approved. What earnings call. There are no earnings without lawsuit wins!
     
  11. anonymous

    anonymous Guest

    Replay:
    1-855-859-2056
    PC : 2019859
     
  12. anonymous

    anonymous Guest

    Looking to merge with OPKO
     
  13. anonymous

    anonymous Guest

    Bankruptcy will come sooner if this merger happens!
     
  14. anonymous

    anonymous Guest

    Your comment makes no sense.

    It’s two sides against each other.

    Roumell wants to sell the lab assets.

    Barry and Elazar want to sell the therapeutics assets.

    There is a proxy vote that just went out to remove Barry from the board.

    Barry just gave up his CFO title to try to keep his seat on the board.

    Someone will win.
     
  15. anonymous

    anonymous Guest

    If OPKO and Enzo merger they will go bankrupt! They are 2 incompetent organizations!
     
  16. anonymous

    anonymous Guest

    Enzo’s Campaign of Misinformation

    In the absence of any viable defense for its own poor track record and litany of strategic missteps, Enzo’s Board has elected to criticize HDF and our independent nominees.

    We own 11.8% of the Company, more than the two Enzo co-founders, the entire Board, and management team combined – despite the co-founders over 40-year tenure and compensation practices that they claim are designed to align their interests with shareholders’.

    On December 23, 2019, Gregory M. Bortz resigned from the Board as a Class I director, effective immediately prior to the commencement of Ms. Fischer’s term as director as of December 30, 2019.
     
  17. anonymous

    anonymous Guest

    i thought bubba boy Barry was going to spend more time overseeing the operation?
     
  18. anonymous

    anonymous Guest

    Anyone read the 2020 Q1 report from Enzo. It is on their website and reads like a fairy tale. This lab is done and Roubani is desperately trying to fend off a takeover. Maybe he should reduce his and the rest of his henchmen salaries. How can a company pay theses salaries when Enzo is in free fall. Lab to lab agreements and a dream of $10m in cost reductions will not save this company! New management is the only hope.
     
  19. anonymous

    anonymous Guest

    You should forward your resume for consideration. From your post you are a raving moron which is exactly what they need more of.
     
  20. anonymous

    anonymous Guest

    Fear not, my friends.
    BW just bought a white horse, to save the day.
    He and his reps have brought over almost 50 samples a day.
    He's my hero.
    I guess that why no one is getting a raise.